首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Assessing daylight & low-dose rate photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ
【24h】

Assessing daylight & low-dose rate photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ

机译:利用光物理,生化和生物损伤指标的生物标志物评估日光和低剂量光动力疗法的疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Sunlight can activate photodynamic therapy (PDT), and this is a proven strategy to reduce pain caused byconventional PDT treatment, but assessment of this and other alternative low dose rate light sources, and their efficacy, has not been studied in an objective, controlled pre-clinical setting. This study used three objective assays to assess the efficacy of different PDT treatment regimens, using PpIX fluorescence as a photophysical measure, STAT3 cross-linking as a photochemical measure, and keratinocyte damage as a photo biological measure.
机译:背景:阳光可以激活光动力疗法(PDT),这是减轻常规PDT治疗所引起的疼痛的一种行之有效的策略,但是尚未对此目标和其他低剂量率替代光源及其功效进行评估,受控的临床前设置。这项研究使用三种客观测定法来评估不同的PDT治疗方案的功效,以PpIX荧光作为光物理方法,STAT3交联作为光化学方法,以及角质形成细胞损伤作为光生物方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号